Prestige Consumer Healthcare (PBH) EBITDA Margin Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -37.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,442.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,299.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3,972.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5,310.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,676.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,106.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2,466.00 |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | -443.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -443.00 |
| Sep 30, 2025 | 46.00 |
| Jun 30, 2025 | 496.00 |
| Mar 31, 2025 | -333.00 |
| Dec 31, 2024 | -241.00 |
| Sep 30, 2024 | 576.00 |
| Jun 30, 2024 | -154.00 |
| Mar 31, 2024 | 185.00 |
| Dec 31, 2023 | -48.00 |
| Sep 30, 2023 | -335.00 |
| Jun 30, 2023 | -496.00 |
| Mar 31, 2023 | -9,241.00 |
| Dec 31, 2022 | 418.00 |
| Sep 30, 2022 | 272.00 |
| Jun 30, 2022 | 171.00 |
| Mar 31, 2022 | 7,857.00 |
| Dec 31, 2021 | 376.00 |
| Sep 30, 2021 | 310.00 |
| Jun 30, 2021 | 870.00 |
| Mar 31, 2021 | 2,987.00 |